# Cardiology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ernest Shackleton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX001-SYN
- Date: 2026-05-26
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ingrid Solberg-Adebayo, MD
- Calendar frame: modern shifted

- Requested by: Cormac Ellingsworth-Daly, MD

## Reason for consultation

Exertional chest tightness and breathlessness for about three months in a 47-year-old heavy smoker who leads a ship-based polar expedition sailing in about four months. Please confirm or exclude obstructive coronary disease, advise on medical therapy and revascularization, and advise whether and how he can safely lead a remote, strenuous, high-latitude expedition. **S**

## History

Mr. Shackleton, a 47-year-old expedition leader, is seen at the request of Dr. Ellingsworth-Daly for three months of exertional chest tightness and breathlessness. Since starting metoprolol two weeks ago the episodes are less frequent but still come two or three times a week on stairs or with a load and pass within three minutes of rest; nitroglycerin has relieved them twice. There is no rest pain, syncope, palpitations, orthopnea, or ankle swelling. He stopped smoking a week ago. He sails in about four months on a long voyage with port calls and weeks at sea far from a hospital, and expects heavy physical work in cold conditions. He wants to lead the expedition and is frank that he would rather not know of anything that could stop him; we agreed that he would hear everything and make the decisions himself. **S**

## Examination

| System | Finding |
|---|---|
| General | Well; blood pressure 134/84, pulse 66 |
| Cardiovascular | Regular rhythm; normal first and second heart sounds with normal splitting; no murmur, gallop, or rub; no carotid bruits; no edema |
| Respiratory | Clear to auscultation bilaterally |

BP 134/84 mmHg; pulse 66 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 85.6 kg; BMI 28 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Ellingsworth-Daly's intake note and results: LDL cholesterol 168 mg/dL, HDL 38, triglycerides 200, total cholesterol 246 mg/dL; HbA1c 5.9%; creatinine 0.98 mg/dL; resting ECG normal. Today: coronary CT angiography with a calcium score of 210, an 80% mixed plaque in the proximal left anterior descending artery with a CT-derived fractional flow reserve of 0.70 distal to it, a 30% plaque in the mid right coronary artery, and no left main disease. Transthoracic echocardiogram: normal left ventricular size and wall motion, LVEF 58%, normal valves, normal right heart, and no interatrial shunt on color Doppler or the agitated-saline study. LVEF: 58%. All results are synthetic.

## Assessment

1. **Chronic coronary disease with stable exertional angina** (I25.118). His typical exertional angina and risk factors gave an intermediate-to-high pretest probability. Coronary CT angiography is a recommended first test at his age and gives the anatomy. It shows a flow-limiting proximal LAD stenosis (CT-FFR 0.70), which explains the angina, with nonobstructive right coronary disease and normal left ventricular function. Without left main disease or a reduced ejection fraction, revascularization in chronic coronary disease improves angina and quality of life but has not been shown to lower the risk of death or heart attack compared with optimized medical therapy. The first step is therefore a higher beta-blocker dose. If angina persists, angiography and a stent to the LAD are reasonable, by shared decision, with dual antiplatelet therapy for six months after an elective stent. **S**
2. **Past heart murmur and episodes of exertional breathlessness**. There is no murmur today, and the echocardiogram shows normal valves, a normal right heart, and no interatrial shunt, so there is no structural explanation such as an atrial septal defect. The present picture is fully explained by the coronary disease. **S**
3. **Fitness for a remote polar expedition**. If he is free of angina on treatment and a symptom-limited exercise test shows good capacity without ischemia, he can sail with precautions. The main risks are an acute coronary event far from a catheter laboratory, bleeding on dual antiplatelet therapy after injury, and the extra cardiac demand of cold and heavy work. Stopping smoking is the single most important change he can make. **S**

## Recommendations

1. Increase metoprolol succinate to 100 mg daily; continue aspirin 81 mg, atorvastatin 80 mg, and sublingual nitroglycerin.
2. Lipid panel 4 to 12 weeks after starting the statin; add ezetimibe if LDL cholesterol is 55 mg/dL or higher.
3. Review in four weeks: if angina persists, invasive coronary angiography by the radial artery with a drug-eluting stent to the proximal LAD, after a shared decision, then aspirin with clopidogrel for six months and aspirin alone after.
4. Cardiac rehabilitation, and supervised exercise before the voyage.
5. Continue varenicline with counseling; no smoking at sea.
6. Before departure: a symptom-limited exercise ECG; a written cardiac summary and medicines with spares; a defibrillator and emergency cardiac medicines aboard; satellite access to cardiology; an evacuation plan to cardiac centers at the ports; and advice on cold stress.
7. No routine surveillance stress testing or imaging afterward; test again only if symptoms change.

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Communication

Discussed with Dr. Ellingsworth-Daly, who saw him the same day. The results and options were explained to Mr. Shackleton with the images, and he agreed with the plan. As he asked, nothing will be shared with his backers without his consent. **S**

## Follow-up

Cardiology review after the primary-care visit in four weeks, to decide on angiography; pre-departure review with the exercise test result. **S**

## Guideline basis

- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023), American Heart Association and American College of Cardiology
- 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024), European Society of Cardiology
- CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026), Aether Forge
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
